{"changeSha256":"6a47daeb2334fcccea3733ee8662ef5cd0d4912d9a56034acbb8a63b9a035e22","changedAt":"2026-07-27","changedFields":[{"after":"An antibody-peptide conjugate candidate. This profile cites a completed ClinicalTrials.gov study record.","before":"An antibody-peptide conjugate candidate represented in ClinicalTrials.gov.","field":"Profile summary"}],"currentVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/maridebart-cafraglutide/versions/2/","version":2},"id":"profile:maridebart-cafraglutide:v2","interpretationBoundary":"This event describes a PeptideScanner public-version change. It does not by itself establish that the cited source changed, that a scientific conclusion changed, or that source monitoring is continuous.","kind":"profile-updated","notice":"We rewrote the profile summary to describe the cited study record more directly. The cited source and status did not change.","peptideSlugs":["maridebart-cafraglutide"],"previousChangeEvent":null,"previousVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/maridebart-cafraglutide/versions/1/","version":1},"schemaVersion":"peptidescanner-public-correction-lineage-event/v1","sourceRecords":[{"id":"ctg-nct07717814-v1","name":"ClinicalTrials.gov","sourceClass":"A","title":"Bioavailability of AMG 133 in Participants With Overweight or Obesity · record history version 1 · last update posted 2026-07-21","url":"https://clinicaltrials.gov/study/NCT07717814?a=1&tab=history","verifiedAt":"2026-07-22"}],"subject":{"slug":"maridebart-cafraglutide","type":"profile"}}